Case number 2018-1285
Purdue Pharma L.P. v. Iancu > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | PURDUE PHARMA L.P. v. IANCU [RULE 36 JUDGMENT] [nonprecedential] (0) |
| May 28, 2019 | 80 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [609744] [18-1285, 18-1286] [MJL] [Entered: 05/28/2019 11:07 AM] (0) |
| Apr 4, 2019 | 79 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [597756] [18-1285, 18-1286] [JAB] [Entered: 04/04/2019 09:39 AM] (0) |
| Apr 2, 2019 | 78 | Submitted after ORAL ARGUMENT by Jennifer Loraine Swize for P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. and Sarah E. Craven for Iancu. Panel: Judge: Dyk , Judge: Mayer , Judge: Bryson. [597169] [JAB] [Entered: 04/02/2019 12:48 PM] (0) |
| Mar 15, 2019 | 77 | Response to notice of oral argument from the Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [593203] [18-1285] [Robert Stander] [Entered: 03/15/2019 01:15 PM] (0) |
| Mar 14, 2019 | 76 | Response to notice of oral argument from the Intervenor Iancu. [592854] [18-1285] [Sarah Craven] [Entered: 03/14/2019 01:08 PM] (0) |
| Feb 22, 2019 | 75 | NOTICE OF ORAL ARGUMENT. Panel: 1904I. Case scheduled Apr 02, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 03/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [588062] [JAB] [Entered: 02/22/2019 03:00 PM] (0) |
| Jan 16, 2019 | 74 | Notice of Appointment of New Solicitor from Patent and Trademark Office. Service: 01/22/2019 by clerk. [579536] [SJ] [Entered: 01/22/2019 09:18 AM] (0) |
| Dec 10, 2018 | 72 | Notice from Intervenor Iancu regarding conflicts with oral argument. Service: 12/10/2018 by email. [570483] [18-1285] [Sarah Craven] [Entered: 12/10/2018 12:55 PM] (0) |
| Dec 10, 2018 | 73 | Notice from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. regarding conflicts with oral argument. Service: 12/10/2018 by email. [570669] [18-1285] [Robert Stander] [Entered: 12/10/2018 07:08 PM] (0) |
| Oct 26, 2018 | 71 | 6 paper copies of the Corrected Confidential Joint Appendix Brief (Vol. I - II) [69] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [560653] [CJF] [Entered: 10/26/2018 12:59 PM] (0) |
| Oct 23, 2018 | 70 | CORRECTED APPENDIX FILED (2 vols.) for P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [67]. Number of Pages: 1069. Service: 10/23/2018 by email. [559948] [SJ] [Entered: 10/24/2018 10:52 AM] (1073) |
| Oct 23, 2018 | 69 | CORRECTED CONFIDENTIAL JOINT APPENDIX FILED (2 vols.) for P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [66]. Number of Pages: 1079. Service: 10/23/2018 by email. The paper copies of the brief should be received by the court on or before 10/31/2018. [559944] [SJ] [Entered: 10/24/2018 10:48 AM] (0) |
| Oct 23, 2018 | 68 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 10/23/2018 by email. [559798] [18-1285] [Robert Stander] [Entered: 10/23/2018 07:42 PM] (3) |
| Oct 23, 2018 | 67 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: CORRECTED JOINT APPENDIX. Service: 10/23/2018 by email. [559797] [18-1285] [Robert Stander] [Entered: 10/23/2018 07:40 PM] (1073) |
| Oct 23, 2018 | 66 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 10/23/2018 by email. [559796] [18-1285] [Robert Stander] [Entered: 10/23/2018 07:35 PM] (0) |
| Oct 23, 2018 | 65 | Notice of Correction to the Brief Doc No. [64], confidential Brief Doc No. [63] for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 10/23/2018 by email. [559795] [18-1285] [Robert Stander] [Entered: 10/23/2018 07:31 PM] (3) |
| Oct 18, 2018 | 64 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: JOINT APPENDIX. Service: 10/18/2018 by email. [558629] [18-1285] This appendix has been corrected. See Doc. No. [70] [Robert Stander] [Entered: 10/18/2018 07:03 PM] (0) |
| Oct 18, 2018 | 63 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: CONFIDENTIAL JOINT APPENDIX Service: 10/18/2018 by email. [558621] [18-1285] This appendix has been corrected. See Doc. No. [69] [Robert Stander] [Entered: 10/18/2018 06:50 PM] (0) |
| Oct 18, 2018 | 62 | 6 paper copies of the Reply Brief [61] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [558508] [CJF] [Entered: 10/18/2018 02:19 PM] (0) |
| Oct 11, 2018 | 61 | REPLY BRIEF FILED for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [60]. Number of Pages: 32. Service: 10/11/2018 by email. The paper copies of the brief should be received by the court on or before 10/23/2018. Appendix is due 10/18/2018. [557801] [SJ] [Entered: 10/16/2018 04:11 PM] (41) |
| Oct 11, 2018 | 60 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: REPLY BRIEF. Service: 10/11/2018 by email. [556481] [18-1285] [Robert Stander] [Entered: 10/11/2018 04:59 PM] (41) |
| Sep 13, 2018 | 59 | **TEXT ONLY** ORDER granting motion to extend time to file brief [57] filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Reply brief is due 10/11/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [549459] [CMP] [Entered: 09/13/2018 11:19 AM] (0) |
| Sep 11, 2018 | 58 | 6 paper copies of the Intervenor Brief [56] received from Intervenor Iancu. [548766] [CJF] [Entered: 09/11/2018 12:04 PM] (0) |
| Sep 11, 2018 | 57 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 10/11/2018 to file the Appellants' Reply Brief. [Consent: unopposed]. Service: 09/11/2018 by email. [548651] [18-1285] [Robert Stander] [Entered: 09/11/2018 09:19 AM] (9) |
| Sep 6, 2018 | 56 | BRIEF FILED for Intervenor Iancu [55]. Number of Pages: 48. Service: 09/06/2018 by email. The paper copies of the brief should be received by the court on or before 09/17/2018. Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. reply brief is due 09/20/2018. [548356] [CMP] [Entered: 09/10/2018 10:57 AM] (59) |
| Sep 6, 2018 | 55 | TENDERED from Intervenor Iancu. Title: INTERVENOR BRIEF. Service: 09/06/2018 by email. [547672] [18-1285] [Sarah Craven] [Entered: 09/06/2018 01:52 PM] (59) |
| Aug 22, 2018 | 54 | **TEXT ONLY** ORDER granting motion to extend time to file brief [53] filed by Intervenor Iancu. Intervenor brief due 09/06/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [544759] [SJ] [Entered: 08/22/2018 04:40 PM] (0) |
| Aug 20, 2018 | 52 | Entry of appearance for Joseph Matal as of counsel for Intervenor Iancu. Service: 08/20/2018 by email. [544022] [18-1285] [Joseph Matal] [Entered: 08/20/2018 12:29 PM] (2) |
| Aug 20, 2018 | 53 | MOTION of Intervenor Iancu to extend the time to 09/06/2018 to file the Intervenor's Brief. [Consent: unopposed]. Service: 08/20/2018 by email. [544026] [18-1285] [Sarah Craven] [Entered: 08/20/2018 12:36 PM] (5) |
| Jul 26, 2018 | 51 | **TEXT ONLY** ORDER granting motion to extend time to file brief [50] filed by Intervenor Iancu. Intervenor brief due 08/27/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [538692] [CMP] [Entered: 07/26/2018 11:15 AM] (0) |
| Jul 23, 2018 | 50 | MOTION of Intervenor Iancu to extend the time to 08/27/2018 to file the Director's Intervenor Brief. [Consent: unopposed]. Service: 07/23/2018 by email. [537834] [18-1285] [Sarah Craven] [Entered: 07/23/2018 02:59 PM] (4) |
| Jul 19, 2018 | 49 | Notice of Withdrawal of Director's Counsel - Nathan K. Kelley. Service: 07/19/2018 by clerk. [536940] [18-1167, 18-1171, 18-1285, 18-1286, 18-1289, 18-1595, 18-1609, 18-1633, 18-1651, 18-1659, 18-1710, 18-1711, 18-1712, 18-1714, 18-1730, 18-1772, 18-1773, 18-1828, 18-1847, 18-1876, 18-1883, 18-1901, 18-1998, 18-2017, 18-2048, 18-2049, 17-1765, 17-1825, 17-2292, 17-2294, 17-2392, 17-2465, 17-2543, 17-2047, 17-2620, 18-1071, 18-1172, 18-1173, 18-1557, 18-1593, 18-1795, 18-1895, 18-2000, 17-2122, 17-2124, 17-2239, 17-2241, 18-1013, 18-1047, 18-1048, 18-1070, 18-1242, 18-1353, 18-1849, 18-1958, 18-1992, 18-1994, 18-1995, 18-2043, 17-2364, 17-2579, 17-2580, 17-2593, 17-2594, 18-1067, 18-1069, 18-1077, 18-1163, 18-1166, 18-1253, 18-1311, 18-1368, 18-1385, 18-1426, 18-1944, 18-1968, 18-2031, 18-2032, 18-2069, 18-2106, 17-2503, 17-2624, 18-1000, 18-1060, 18-1065, 18-1066, 18-1416, 18-1461, 18-2090, 15-1242, 15-1944, 15-1945, 15-1946, 16-1794, 16-2222, 16-2470, 16-2548, 16-2640, 16-2669, 16-2736, 17-1159, 17-1265, 17-1266, 17-1268, 17-1362, 17-1425, 17-1486, 17-1578, 17-1582, 17-1629, 17-1666, 17-1722, 17-1827, 17-1849, 17-1870, 17-1953, 17-1954, 17-1955, 17-1957, 17-1962, 17-1963, 17-2037, 17-2038, 17-2069, 17-2208, 17-2232, 17-2244, 17-2255, 17-2263, 17-2361, 17-2424, 17-2426, 17-2447, 17-2524, 18-1085, 18-1088, 18-1122] [TAR] [Entered: 07/19/2018 10:11 AM] (2) |
| Jul 6, 2018 | 48 | 6 paper copies of the Opening Brief [47] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [534129] [CJF] [Entered: 07/06/2018 04:06 PM] (0) |
| Jul 2, 2018 | 47 | BRIEF FILED for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [46]. Number of Pages: 66. Service: 07/02/2018 by email. The paper copies of the brief should be received by the court on or before 07/11/2018. Intervenor brief is due 08/13/2018. [533474] [CFT] [Entered: 07/03/2018 01:36 PM] (201) |
| Jul 2, 2018 | 46 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: OPENING BRIEF. Service: 07/02/2018 by email. [533253] [18-1285] [Robert Stander] [Entered: 07/02/2018 06:59 PM] (201) |
| Jun 18, 2018 | 45 | Entry of appearance for Mary L. Kelly as of counsel for Intervenor Iancu. Service: 06/18/2018 by email. [530172] [18-1285] [Mary Kelly] [Entered: 06/18/2018 10:27 AM] (2) |
| Jun 18, 2018 | 44 | Docketing Statement for the Intervenor Iancu. Service: 06/18/2018 by email. [530142] [18-1285] [Sarah Craven] [Entered: 06/18/2018 09:33 AM] (3) |
| Jun 11, 2018 | 43 | Entry of appearance for Sarah E. Craven as of counsel for Intervenor Iancu. Service: 06/11/2018 by email. [528522] [18-1285] [Sarah Craven] [Entered: 06/11/2018 04:28 PM] (2) |
| May 21, 2018 | 42 | Official caption revised to reflect Notice of Intervention from PTO. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [523080] [18-1285, 18-1286] [CFT] [Entered: 05/21/2018 08:55 AM] (0) |
| May 18, 2018 | 40 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor - Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523022] [18-1285] [Thomas Krause] [Entered: 05/18/2018 05:16 PM] (2) |
| May 18, 2018 | 41 | Entry of appearance for Nathan K. Kelley as principal counsel for Intervenor - Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523026] [18-1285] [Nathan Kelley] [Entered: 05/18/2018 05:23 PM] (2) |
| May 18, 2018 | 39 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523021] [18-1285] [Thomas Krause] [Entered: 05/18/2018 05:14 PM] (3) |
| May 11, 2018 | 38 | ORDER granting motion to extend time to file brief [37] filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. No further extensions should be anticipated. Brief due 07/02/2018. Service as of this date by the Clerk of Court. [520974] [CFT] [Entered: 05/11/2018 10:24 AM] (2) |
| May 10, 2018 | 37 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 07/02/2018 to file the Appellants' Brief. [Consent: unopposed]. Service: 05/10/2018 by email. [520878] [18-1285] [Robert Stander] [Entered: 05/10/2018 07:34 PM] (8) |
| Apr 18, 2018 | 36 | ORDER filed. Amneal and Kashiv's motions to substitute or intervene [18] [508870-2] are denied. The revised official caption and short caption are revised based on Amneal's non-participation in these appeals and are reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days from the date of this order whether he wishes to intervene in these appeals. If the Director elects to participate as intervenor, his briefs shall be due no later than 40 days from the date of filing of Purdue's opening briefs. Purdue may file its reply briefs no later than 14 days from the date of filing of the Director's briefs. If the Director elects not to participate, Purdue shall file its appendixes no later than 20 days from the date of filing of its briefs. Service: 04/18/2018 by clerk. [514763] [18-1285, 18-1710] [LMS] [Entered: 04/18/2018 10:40 AM] (5) |
| Mar 30, 2018 | 35 | Notice from Appellee Amneal Pharmaceuticals LLC from Kashiv Pharma, LLC Notice of Non-Participation. Service: 03/30/2018 by email. [509571] [18-1285] [Thomas Meloro] [Entered: 03/30/2018 01:19 PM] (4) |
| Mar 28, 2018 | 34 | Note to file: 18-1710 (COMPANION started 03/28/2018) with 18-1285. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [508688] [18-1285, 18-1710] [CAB] [Entered: 03/28/2018 01:42 PM] (0) |
| Mar 12, 2018 | 33 | REPLY of Appellee Amneal Pharmaceuticals LLCKashiv Pharma, LLC to response filed by Appellants in 18-1285 , Doc. No [30]. Service: 03/12/2018 by email. [504343] [Thomas Meloro] [Entered: 03/12/2018 04:46 PM] (15) |
| Mar 7, 2018 | 32 | ORDER filed. The motion for an extension of time [29] is granted. The appellants' opening brief is due May 22, 2018. Service: 03/07/2018 by clerk. [503071] [LMS] [Entered: 03/07/2018 09:51 AM] (2) |
| Mar 6, 2018 | 31 | RESPONSE of Appellee Amneal Pharmaceuticals LLCfrom Kashiv Pharma, LLC to the motion to extend time to file appellant/petitioner principal brief [29] filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. in 18-1285. Service: 03/06/2018 by email. [502803] [Thomas Meloro] [Entered: 03/06/2018 10:49 AM] (6) |
| Mar 5, 2018 | 30 | RESPONSE of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to the motion to substitute party [18] filed by Appellee Amneal Pharmaceuticals LLC in 18-1285 , motion to withdraw party [18] filed by Appellee Amneal Pharmaceuticals LLC in 18-1285 , motion for leave to intervene [18] filed by Appellee Amneal Pharmaceuticals LLC in 18-1285. Service: 03/05/2018 by email. [502718] [Robert Stander] [Entered: 03/05/2018 08:15 PM] (32) |
| Mar 5, 2018 | 29 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 05/22/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: partial consent]. Service: 03/05/2018 by email. [502716] [Robert Stander] [Entered: 03/05/2018 08:13 PM] (10) |
| Feb 28, 2018 | 28 | ORDER filed. The motion for an extension of time [26] is granted. Service: 02/28/2018 by clerk. [501805] [LMS] [Entered: 02/28/2018 02:51 PM] (2) |
| Feb 27, 2018 | 27 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Appellants' motion [26] did not include a certificate of interest (COI). CORRECTION: Pursuant to FCR 47.4(b), motions must contain a COI. Please ensure future motions include the COI. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [501338] [MJL] [Entered: 02/27/2018 11:36 AM] (0) |
| Feb 26, 2018 | 26 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 03/05/2018 at 11:59 pm file a response/reply to the confidential document [19], motion to substitute party [18], motion to withdraw party [18], motion for leave to intervene [18]. [Consent: not addressed]. Service: 02/26/2018 by email. [501205] [Robert Stander] [Entered: 02/26/2018 07:03 PM] (5) |
| Feb 20, 2018 | 25 | Entry of appearance for Robert Stander as of counsel for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 02/20/2018 by email. [499275] [Robert Stander] [Entered: 02/20/2018 11:30 AM] (2) |
| Feb 15, 2018 | 24 | Corrected Entry of appearance for Heather M. Schneider as of counsel for Kashiv Pharma, LLC. Service: 02/15/2018 by email. [497999] [Thomas Meloro] [Entered: 02/15/2018 11:15 AM] (2) |
| Feb 15, 2018 | 23 | Corrected Entry of appearance for Thomas J. Meloro as principal counsel for Kashiv Pharma, LLC. Service: 02/15/2018 by email. [497997] [Thomas Meloro] [Entered: 02/15/2018 11:11 AM] (2) |
| Feb 15, 2018 | 22 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [21] , attorney entry of appearance Document No. [20] is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [497957] [FMS] [Entered: 02/15/2018 09:30 AM] (0) |
| Feb 14, 2018 | 21 | Entry of appearance for Heather M. Schneider as of counsel for Kashiv Pharma, LLC. Service: 02/14/2018 by email. [497880] [Thomas Meloro] [Entered: 02/14/2018 07:16 PM] (0) |
| Feb 14, 2018 | 20 | Entry of appearance for Thomas J. Meloro as principal counsel for Kashiv Pharma, LLC. Service: 02/14/2018 by email. [497878] [Thomas Meloro] [Entered: 02/14/2018 07:12 PM] (0) |
| Feb 14, 2018 | 19 | Sealed or confidential document received [MOTION of Kashiv Pharma, LLC Appellee Amneal Pharmaceuticals LLC to substitute party, to withdraw party, Amneal Pharmaceuticals LLC, as a party to this appeal, and for leave to intervene] (corresponding to Doc No. [18]),(corresponding to Doc No. [18]),(corresponding to Doc No. [18]) for Appellee Amneal Pharmaceuticals LLC. Service: 02/14/2018 by email. [497877] [Thomas Meloro] [Entered: 02/14/2018 07:07 PM] (0) |
| Feb 14, 2018 | 18 | MOTION of Kashiv Pharma, LLC Appellee Amneal Pharmaceuticals LLC to substitute party. Any response is due within 10 days of service, to withdraw party, Amneal Pharmaceuticals LLC, as a party to this appeal. Any response is due within 10 days of service, for leave to intervene. Any response is due within 10 days of service [Consent: opposed]. Service: 02/14/2018 by email. [497874] [Thomas Meloro] [Entered: 02/14/2018 06:53 PM] (64) |
| Jan 22, 2018 | 17 | Certified list from the United States Patent and Trademark Office. Service: 01/22/2018 by email. Appellant/Petitioner's brief is due 03/23/2018. [491630] [FMS] [Entered: 01/22/2018 04:57 PM] (90) |
| Jan 4, 2018 | 16 | Entry of appearance for Heather M. Schneider as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 01/04/2018 by email. [487363] [Heather Schneider] [Entered: 01/04/2018 01:26 PM] (2) |
| Jan 4, 2018 | 15 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellee Amneal Pharmaceuticals LLC. Service: 01/04/2018 by email. [487360] [Thomas Meloro] [Entered: 01/04/2018 01:18 PM] (2) |
| Jan 4, 2018 | 14 | Amended Entry of appearance for Tedd W. Van Buskirk as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 01/04/2018 by email. [487345] [Tedd Van Buskirk] [Entered: 01/04/2018 12:36 PM] (1) |
| Dec 22, 2017 | 13 | Docketing Statement for the Appellee Amneal Pharmaceuticals LLC. Service: 12/22/2017 by email. [485192] [Tedd Van Buskirk] [Entered: 12/22/2017 12:39 PM] (4) |
| Dec 22, 2017 | 12 | Certificate of Interest for the Appellee Amneal Pharmaceuticals LLC. Service: 12/22/2017 by email. [485189] [Tedd Van Buskirk] [Entered: 12/22/2017 12:38 PM] (3) |
| Dec 22, 2017 | 11 | Entry of appearance for Michael H. Teschner as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 12/22/2017 by email. [485186] [Michael Teschner] [Entered: 12/22/2017 12:36 PM] (2) |
| Dec 22, 2017 | 10 | Entry of appearance for Tedd W. Van Buskirk as principal counsel for Appellee Amneal Pharmaceuticals LLC. Service: 12/22/2017 by email. [485184] [Tedd Van Buskirk] [Entered: 12/22/2017 12:33 PM] (2) |
| Dec 20, 2017 | 9 | Note to file: The following cases are associated:18-1285 Lead with 18-1286 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [484261] [18-1285, 18-1286] [FMS] [Entered: 12/20/2017 01:36 PM] (0) |
| Dec 20, 2017 | 8 | ORDER consolidating appeals (18-1285 Lead with 18-1286 Consolidated ). Service as of this date by Clerk of Court. [484259] [18-1285, 18-1286] [FMS] [Entered: 12/20/2017 01:35 PM] (2) |
| Dec 14, 2017 | 7 | Docketing Statement for the Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482679] [Jennifer Swize] [Entered: 12/14/2017 01:48 PM] (4) |
| Dec 14, 2017 | 6 | Certificate of Interest for the Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482678] [Jennifer Swize] [Entered: 12/14/2017 01:47 PM] (3) |
| Dec 14, 2017 | 5 | Entry of appearance for John J. Normile as of counsel for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482677] [Jennifer Swize] [Entered: 12/14/2017 01:45 PM] (2) |
| Dec 14, 2017 | 4 | Entry of appearance for Gasper J. LaRosa as of counsel for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482675] [Jennifer Swize] [Entered: 12/14/2017 01:44 PM] (2) |
| Dec 14, 2017 | 3 | Entry of appearance for Gregory A. Castanias as principal counsel for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482674] [Jennifer Swize] [Entered: 12/14/2017 01:43 PM] (2) |
| Dec 14, 2017 | 2 | Entry of appearance for Jennifer L. Swize as of counsel for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/14/2017 by email. [482673] [Jennifer Swize] [Entered: 12/14/2017 01:36 PM] (2) |
| Dec 8, 2017 | 1 | Appeal docketed. Received: 12/04/2017. [481388] Entry of Appearance due 12/22/2017. Certificate of Interest is due on 12/22/2017. Docketing Statement due 12/22/2017. Certified List due on 01/17/2018. [FMS] [Entered: 12/08/2017 04:55 PM] (51) |
